November 09, 2020

Novavax On Track To Begin U.S. Trial Of COVID-19 Vaccine This Month-Reuters

Novavax Inc said on Monday it was on track to begin a delayed U.S.-based late-stage study of its experimental coronavirus vaccine later this month. The company also said the vaccine, NVX-CoV2373, had gained the U.S. Food and Drug Administration’s “fast-track” status and that expected data from the trial could support U.S. authorization and approval. Reuters, 11/09/2020